4//SEC Filing
Bensen Daniel 4
Accession 0000950170-24-026365
CIK 0001863127other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:40 PM ET
Size
8.4 KB
Accession
0000950170-24-026365
Insider Transaction Report
Form 4
Bensen Daniel
Chief Discovery Officer
Transactions
- Sale
Common Stock
2024-03-01$20.04/sh−2,900$58,112→ 439,936 total - Sale
Common Stock
2024-03-04$20.08/sh−5,063$101,654→ 434,873 total - Sale
Common Stock
2024-03-05$20.02/sh−1,189$23,802→ 433,684 total
Footnotes (4)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 7, 2022.
- [F2]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.14. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F3]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.44. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
- [F4]Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range between $20.00 to $20.10. Detailed information on the exact number of shares sold at each sale price can be obtained from the Issuer upon request.
Documents
Issuer
Tyra Biosciences, Inc.
CIK 0001863127
Entity typeother
Related Parties
1- filerCIK 0001880946
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:40 PM ET
- Size
- 8.4 KB